Annual report pursuant to Section 13 and 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details)

Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2022
Restructuring costs, net of adjustments									$ 33,987
Restructuring costs	$ 21,072	$ 1,273	$ 11,424						12,245	$ 3,829	$ 1,640
Cash payments									(7,682)
Non-cash adjustments									(25,354)
Adjustments									219
Accrued restructuring actions balances	952								952
Restructuring reserves, Ending Balance							$ 0			0
Corporate
Restructuring costs, net of adjustments									2,180
Diagnostics and Genomics
Restructuring costs, net of adjustments									1,231
Restructuring costs						$ 1,185		$ 242
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]											Selling, general and administrative
Cash payments								(1,143)
Adjustments								(284)
Protein Sciences
Restructuring costs, net of adjustments									30,576
Restructuring costs									200
Protein Sciences \| QT Holdings Corporation
Restructuring costs				$ 2,170						$ 2,170
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]										Selling, general and administrative
Cash payments							(2,005)
Adjustments							(165)
Cost of Sales
Restructuring costs, net of adjustments									3,349
Selling, General and Administrative Expenses
Restructuring costs, net of adjustments									30,638
Selling, General and Administrative Expenses \| Diagnostics and Genomics
Restructuring costs, net of adjustments										$ 1,399
Employee severance
Restructuring costs, net of adjustments									5,643
Restructuring costs	$ 409	$ 133	$ 4,882
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of sales, Selling, general and administrative	Cost of sales, Selling, general and administrative	Cost of sales, Selling, general and administrative
Cash payments									(4,882)
Adjustments									219
Accrued restructuring actions balances	$ 761								761
Employee severance \| Corporate
Restructuring costs, net of adjustments									1,153
Employee severance \| Diagnostics and Genomics
Restructuring costs, net of adjustments									1,007
Restructuring costs						$ 639
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]						Selling, general and administrative					Selling, general and administrative
Cash payments								(589)
Adjustments								(50)
Employee severance \| Protein Sciences
Restructuring costs, net of adjustments									3,483
Accrued restructuring actions balances									897
Restructuring costs										$ 1,677
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]										Selling, general and administrative
Cash payments									(1,118)	$ (762)
Adjustments									221	18
Accrued restructuring actions balances							897			897
Employee severance \| Protein Sciences \| QT Holdings Corporation
Restructuring costs				1,328						$ 1,328
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]										Selling, general and administrative
Cash payments							(1,233)
Adjustments							(95)
Employee severance \| Selling, General and Administrative Expenses \| Diagnostics and Genomics
Restructuring costs, net of adjustments											$ 649
Asset-related and other
Restructuring costs, net of adjustments									6,381
Restructuring costs	$ 4,737	$ 1,140	$ 504
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of sales, Selling, general and administrative	Cost of sales, Selling, general and administrative	Cost of sales, Selling, general and administrative
Cash payments									(2,800)
Non-cash adjustments									(3,391)
Accrued restructuring actions balances	$ 190								190
Asset-related and other \| Corporate
Restructuring costs, net of adjustments									1,027
Asset-related and other \| Diagnostics and Genomics
Restructuring costs, net of adjustments									224
Asset-related and other \| Protein Sciences
Restructuring costs, net of adjustments									5,130
Impairment of assets held-for-sale
Restructuring costs, net of adjustments									21,963
Restructuring costs	$ 15,926		$ 6,038
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of sales, Selling, general and administrative		Cost of sales, Selling, general and administrative
Non-cash adjustments									(21,963)
Impairment of assets held-for-sale \| Protein Sciences
Restructuring costs, net of adjustments									$ 21,963
Employee Severance on Relocation of US Plant [Member]
Restructuring costs					$ 200
Asset impairment and other \| Diagnostics and Genomics
Restructuring costs						$ 546		$ 242
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]						Selling, general and administrative		Selling, general and administrative			Selling, general and administrative
Cash payments								$ (554)
Adjustments								$ (234)
Asset impairment and other \| Protein Sciences \| QT Holdings Corporation
Restructuring costs				$ 842						$ 842
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]										Selling, general and administrative
Cash payments							(772)
Adjustments							$ (70)
Asset impairment and other \| Selling, General and Administrative Expenses \| Diagnostics and Genomics
Restructuring costs, net of adjustments											$ 750